Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica.
about
Aquaporin 4 and neuromyelitis opticaPhysiological roles of aquaporin-4 in brainImmunology of neuromyelitis optica: a T cell-B cell collaborationMolecular pathogenesis of neuromyelitis opticaTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesOptic neuritis in neuromyelitis optica.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Transient hyperckemia in the setting of neuromyelitis optica (NMO).Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.The treatment of neuromyelitis optica.Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis opticaThe intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer modelComplement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arraysSuper-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.Aquaporin water channels in the nervous system.Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgGNeurodegeneration in multiple sclerosis and neuromyelitis optica.The binding property of a monoclonal antibody against the extracellular domains of aquaporin-4 directs aquaporin-4 toward endocytosisNeuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures.Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.Pattern Recognition of the Multiple Sclerosis Syndrome.Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease
P2860
Q24613666-E9D195EA-7B1E-4DFB-AA66-5C8CE1ED9578Q26866009-3E52B043-7929-4C9C-B6BA-156B39FAC669Q27016045-D3338F35-1A04-4ABC-9F6E-7F286486FBE5Q27021535-109D12E8-8C74-48A9-8B89-8ABA7555ED59Q28245749-1ACD7D37-0544-4372-9A1D-27492746BBCEQ30610471-D19FA8CD-579A-403A-936F-7F8FB07A8DC4Q30785267-A57A85DF-0F23-4990-A64E-0A4BBA401DC1Q30826839-1F35337F-1F0E-4B09-9FE8-74639369FAAAQ34377212-39F3DBBE-C6A2-4C8B-8636-04CEFEC4384FQ34399291-E38011C4-9968-4340-87BC-1A6EEF32B57AQ34497097-C894560D-3845-46E9-9AA0-2CA6A521551FQ34919661-7653871E-C4AC-42C2-84EB-84A18ACB48EFQ35242214-4EE129B0-608F-441A-94E3-1054EC48EA93Q35922319-420BCE5D-1634-489A-97B6-58F7D2567483Q36451210-41EDB8F5-97B4-44DF-B051-4733DDB7DD82Q36635664-1C6352D5-966C-4032-99D8-45C80DCC6177Q36650382-DF739B4F-960D-43D9-8393-33B979D4A93DQ36911907-971D0AB3-A90F-4B25-B7D8-2A6021BE0229Q37066291-4CC19FD5-4236-48EF-8B1F-911F329D9E12Q37638498-2085DEEB-9142-44F4-8257-2C302B2DC816Q38965274-89D9AC87-3E2E-4BC3-9F30-7079AADCF067Q41683003-02E0DF6B-3937-4AD6-9D76-D083F55ED85DQ42272997-AC8E6697-17EF-4317-A9A3-9921A2A7744AQ42844764-B1ACEE55-CC6F-4A8D-8567-7893A0FB306EQ43105705-74AF8CCC-7C7B-437A-ACF3-04322B0D318CQ44938114-1D98D179-F736-4098-A00F-FB96032133BCQ46591339-44B245F6-6965-4CE6-8678-CC5989C7D83EQ47096340-7B3656F3-2DEB-4454-B8D8-281608B4B025Q57725942-9FBBCFE2-31FE-4361-A947-820AF00F9A37
P2860
Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Evidence against cellular inte ...... ter 2 in neuromyelitis optica.
@ast
Evidence against cellular inte ...... ter 2 in neuromyelitis optica.
@en
type
label
Evidence against cellular inte ...... ter 2 in neuromyelitis optica.
@ast
Evidence against cellular inte ...... ter 2 in neuromyelitis optica.
@en
prefLabel
Evidence against cellular inte ...... ter 2 in neuromyelitis optica.
@ast
Evidence against cellular inte ...... ter 2 in neuromyelitis optica.
@en
P2093
P2860
P356
P1476
Evidence against cellular inte ...... ter 2 in neuromyelitis optica.
@en
P2093
A S Verkman
Jeffrey L Bennett
Julien Ratelade
P2860
P304
45156-45164
P356
10.1074/JBC.M111.297275
P407
P577
2011-11-08T00:00:00Z